ArticleOrphanet journal of rare diseases2022

Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018.

Min Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.